Claims for Patent: 10,017,732
✉ Email this page to a colleague
Summary for Patent: 10,017,732
| Title: | Cell culture compositions with antioxidants and methods for polypeptide production |
| Abstract: | Cell culture media comprising antioxidants are provided herein as are methods of using the media for cell culturing and polypeptide production from cells. Compositions comprising polypeptides, such as therapeutic polypeptides, produced by the methods herein are also provided. |
| Inventor(s): | Vijayasankaran Natarajan, Meier Steven J., Varma Sharat, Yang Yi |
| Assignee: | GENENTECH, INC. |
| Application Number: | US14211416 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,017,732 |
Details for Patent 10,017,732
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | February 19, 2002 | ⤷ Get Started Free | 2034-03-14 |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | February 26, 2004 | ⤷ Get Started Free | 2034-03-14 |
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | June 30, 2006 | ⤷ Get Started Free | 2034-03-14 |
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | August 10, 2012 | ⤷ Get Started Free | 2034-03-14 |
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | October 13, 2016 | ⤷ Get Started Free | 2034-03-14 |
| Genentech, Inc. | LUCENTIS | ranibizumab | Injection | 125156 | March 20, 2018 | ⤷ Get Started Free | 2034-03-14 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,017,732
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201805630 | ⤷ Get Started Free |
| South Africa | 201506155 | ⤷ Get Started Free |
| World Intellectual Property Organization (WIPO) | 2014145098 | ⤷ Get Started Free |
| United States of America | 2024400976 | ⤷ Get Started Free |
| United States of America | 2021017488 | ⤷ Get Started Free |
| United States of America | 2019144817 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
